In this week’s MTB Roundup: The link between epigenetics and mental illness, an implantable solution to the opioid crisis, MIT’s game-changing drug machine and more…
Xperii, a marketplace that connects researchers with study and clinical trial participants, is gearing up to launch their platform this summer.
Dr. Dimitris Bertsimas, professor of operational research at MIT has devised a machine-learning model to help advise patients and doctors about the relative benefits of various combinational chemotherapy treatments, and help researchers predict the toxicity and survivability of new combinations of drugs that have previously not been tried together.
In this week's MTB Roundup: Boston's newest immunotherapy startup, infographics on mental health outcomes and costs, a "second-skin" out of MIT and more...
Detecting Lung Cancer With A Single Breath; Astraeus Technologies Gunning To Win the M2D2 $100K Challenge »
Astraeus Technologies has won numerous prizes for their cancer diagnostic device. Next week they’re headed to the Massachusetts Medical Device Development Center at UMass to compete in the M2D2 $100K Challenge.
Ben Harvatine has developed the Jolt Sensor, a device that monitors hard hits on the field and helps athletes make informed decisions about returning to play.
Each year, 2.5 million seniors are treated in emergency departments for fall-related injuries. MIT professor Dina Katabi is hoping to change this with a revolutionary new device.
Winning teams built apps focusing either on cost-cutting measures in clinical practice or lightening physicians’ workloads by automating complex tasks
DRACOs, a broad spectrum anti-viral approach, has potential to end epidemics and save countless lives, but will it raise enough funds to become a reality?
Last month, the FDA approved manufacture of the world’s first 3D printed pill Spritam, an anti-epileptic seizure drug. We caught up with Michael Cima, one of the inventors of 3D printing and a professor at MIT, to find out what this development means for the future of the pharmaceutical industry.